Risk factors for peripheral venous disease resemble those for venous thrombosis: The San Diego Population Study

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 8, 2010, Pages 1730-1735

  Cushman, Mary ^a   Callas, P W ^a   Denenberg, J O ^b   Bovill, E G ^a   Criqui, M H ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood coagulation; Deep vein thrombosis; Epidemiology; Risk factors; Venous insufficiency

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; D DIMER; PROTHROMBIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL VEIN DISEASE; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; RISK FACTOR; ULTRASOUND; VEIN DISEASE;

AGE FACTORS; AGED; CALIFORNIA; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PROTHROMBIN; RISK FACTORS; VENOUS THROMBOSIS;

EID: 77958583945     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03924.x     Document Type: Article

References (29)

1. Prandoni P, Lensing A, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan A, Polistena P, Bernardi E, Prins M. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996, 125:1-7.
2. Mohr DN, Silverstein MD, Heit JA, Petterson TM, O'Fallon WM, Melton LJ. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc 2000, 75:1249-56.
3. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004, 164:17-26.
4. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, Ginsberg JS. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008, 149:698-707.
5. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995, 274:335-7.
6. Cronin CG, Lohan DG, Keane M, Roche C, Murphy JM. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. AJR Am J Roentgenol 2007, 189:162-70. http://dx.doi.org/10.2214/AJR.07.2067, 189/1/162 [pii]
7. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:381S-453S.
8. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 2009, CD004318. http://dx.doi.org/10.1002/14651858.CD004318.pub2
9. Welch HJ, Young CM, Semegran AB, Iafrati MD, Mackey WC, O'Donnell TF. Duplex assessment of venous reflux and chronic venous insufficiency: the significance of deep venous reflux. J Vasc Surg 1996, 24:755-62.
10. Wille-Jorgensen P, Jorgensen LN, Crawford M. Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost 2005, 93:236-41.
11. Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003, 101:1243-8.
12. Criqui MH, Jamosmos M, Fronek A, Denenberg JO, Langer RD, Bergan J, Golomb BA. Chronic venous disease in an ethnically diverse population: the San Diego population study. Am J Epidemiol 2003, 158:448-56.
13. Langer RD, Ho E, Denenberg JO, Fronek A, Allison M, Criqui MH. Relationships between symptoms and venous disease: the San Diego population study. Arch Intern Med 2005, 165:1420-4. http://dx.doi.org/10.1001/archinte.165.12.1420, 165/12/1420 [pii]
14. Fronek A, Criqui MH, Denenberg J, Langer RD. Common femoral vein dimensions and hemodynamics including Valsalva response as a function of sex, age, and ethnicity in a population study. J Vasc Surg 2001, 33:1050-6.
15. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004, 40:1248-52.
16. Emmerich J, Vossen CY, Callas PW, Demers C, Naud S, Long GL, Couture P, Rosendaal FR, Bovill EG. Chronic venous abnormalities in symptomatic and asymptomatic protein C deficiency. J Thromb Haemost 2005, 3:1428-31.
17. Munkvad S, Jorgensen M. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol 1996, 134:296-8.
18. Maessen-Visch MB, Hamulyak K, Tazelaar DJ, Crombag NH, Neumann HA. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol 1999, 135:41-4.
19. Gaber Y, Siemens HJ, Schmeller W. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers. Br J Dermatol 2001, 144:546-8.
20. Hafner J, Kuhne A, Schar B, Bombeli T, Hauser M, Luthi R, Hanseler E. Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers. Arch Dermatol 2001, 137:599-603.
21. Darvall KA, Sam RC, Adam DJ, Silverman SH, Fegan CD, Bradbury AW. Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls. J Vasc Surg 2009, 49:1235-41. http://dx.doi.org/10.1016/j.jvs.2008.12.017, S0741-5214(08)02204-0 [pii]
22. Kahn SR, Kearon C, Julian JA, Mackinnon B, Kovacs MJ, Wells P, Crowther MA, Anderson DR, Van Nguyen P, Demers C, Solymoss S, Kassis J, Geerts W, Rodger M, Hambleton J, Ginsberg JS. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost 2005, 3:718-23.
23. Stain M, Schonauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Kyrle PA, Eichinger S. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005, 3:2671-6.
24. Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, Tormene D, Mosena L, Pagnan A, Girolami A. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004, 141:249-56.
25. van't Veer C, Kalafatis M, Bertina RM, Simioni P, Mann KG. Increased tissue factor-initiated prothrombin activation as a result of the Arg506 - > Gln mutation in factor VLEIDEN. J Biol Chem 1997, 272:20721-9.
26. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 2004, 351:1081-8.
27. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurence of deep-vein thrombosis. Lancet 1995, 345:152-5.
28. Andreescu ACM, Cushman M, Rosendaal FR. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study. Thromb Haemost 2002, 87:47-51.
29. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR. Coagulation factors, inflammation markers, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Med 2002, 113:636-42.